Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Change Just $300 into much MUCH MORE!!! -- Ignore unavailable to you. Want to Upgrade?

To: Kerry S. Nelson who wrote (45)	2/26/1998 5:03:00 PM
From: Daniel Miller	Respond to of 174

I had a problem with it. My trade went in and it said I had isfufficient funds. I am extremly angry im putting in the order again for tomorrow. But so far all my picks have gone up. Iyt moved up greatly. Hopefully this will improve my reputation and more will join the thread.

To: Kerry S. Nelson who wrote (45)	2/26/1998 5:37:00 PM
From: Daniel Miller	Read Replies (1) \| Respond to of 174

Well, todays story. I put a sell order into NETZ. Then a buy in ADOT. Also a limit sell order in ADOT for .50. Unfoutanetly, the buy order for ADOT went in before the sell order of NETZ and I had insufficient funds. Otherwise I would have made a 350% gains already, turning my $300 into $1,200. In 2 days!! Look at what this 12 year old can do!!

To: Kerry S. Nelson who wrote (45)	2/26/1998 5:39:00 PM
From: Daniel Miller	Respond to of 174

HNLY is another stock im watching the buy for tomorrow is still set on ADOT.

To: Kerry S. Nelson who wrote (45)	2/28/1998 9:41:00 PM
From: Daniel Miller	Respond to of 174

Check out LANZ. I cant believe nobody has seen it yet. It seems great. They came out with 2 new products. They aren't BIG products yet they are something that every hospital in the near future can possably be using. Check out this news article I took off the net. This stock is not going to be one of my short term investments rather it will be an investment holding for 1 year starting Mon. I will get another $300 to invest in more penny stocks dont worry. I think this stock will turn into $5 stock by next year. PR Newswire, Wednesday, February 25, 1998 at 08:58 SAN MARCOS, Calif., Feb. 25 /PRNewswire/ -- Lancer Orthodontics, Inc. (NASDAQ:LANZ) has announced the addition of two major orthodontic group practice accounts. The accounts have the potential to increase the company's domestic sales by over 12 percent during the next year. "We have specifically targeted group practices and plan to be very aggressive as we continue to penetrate this fast growing market within the orthodontic specialty," said Doug Miller, President and COO of Lancer Orthodontics. "Lancer is uniquely positioned to profitably capture a substantial portion of this market due to its improved manufacturing efficiencies and lower overhead. The group practice market is a fast growing market segment due to the need by the profession to consolidate and reduce overall costs." At the same time the Company also announced two new product additions: glow-in-the-dark chains and ties and dimpled arch wires. It is estimated that over 70% of orthodontic treatments have been initiated for patients between the ages of 9 and 18. The glow-in-the-dark chains and ties are designed to increase patient compliance and make treatment more enjoyable for this younger market segment. Lancer's new dimpled arch wires are designed to enhance overall treatment by enabling orthodontists to more accurately position the arch wire. In addition, once the dimpled arch wire is in place, it does not move. This increases the orthodontist's efficiency by eliminating the need for adjustments. The Company expects its new products to enhance its position in the market place. Lancer Orthodontics develops, manufactures and markets advanced orthodontic products worldwide. This press release contains forward looking information that is based on current expectations and therefore it necessarily involves risk and uncertainties. Although the Company believes that the basis for the forward looking statements are reasonable, there can be no assurance that the results anticipated in the forward looking statements will be realized. Many factors could influence the results contemplated and therefore there is no assurance that the company's products will become commercially successful.